Loading…
Variations of ganglioside biosynthetic pathways in the phenotype conversion from myofibroblasts to lipocytes in murine hepatic stellate cell line
GRX cell line represents hepatic stellate cell and can be transformed from an actively proliferation myofibroblast phenotype into a quiescent fat-storing lipocyte phenotype. Both express the same gangliosides (GM3, GM2, GM1 and GD1a), which are resolved as doublets on HPTLC. Upper/lower band ratio i...
Saved in:
Published in: | Molecular and cellular biochemistry 2007-09, Vol.303 (1-2), p.121-130 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c441t-6c89e888f125b8417af0a99fe14d4efe572dc58c9352db1a237f0319f1158b213 |
---|---|
cites | cdi_FETCH-LOGICAL-c441t-6c89e888f125b8417af0a99fe14d4efe572dc58c9352db1a237f0319f1158b213 |
container_end_page | 130 |
container_issue | 1-2 |
container_start_page | 121 |
container_title | Molecular and cellular biochemistry |
container_volume | 303 |
creator | de Aguirres, Aline B Mello, Paola A Andrade, Claudia M. B Breier, Ana Carolina Margis, Rogério Guaragna, Regina M Borojevic, Radovan Guma, Fátima C. R Trindade, Vera M. T |
description | GRX cell line represents hepatic stellate cell and can be transformed from an actively proliferation myofibroblast phenotype into a quiescent fat-storing lipocyte phenotype. Both express the same gangliosides (GM3, GM2, GM1 and GD1a), which are resolved as doublets on HPTLC. Upper/lower band ratio is increased in lipocyte-like cells and the upper band is composed by ceramides with long-chain fatty acids. This study evaluated the contribution of de novo synthesis, sphingosine and Golgi recycling pathways on ganglioside biosynthesis, in both phenotypes. Cells were preincubated with 5 mM β-chloroalanine (SPT: serine palmitoyltransferase inhibitor) or with 25 μM fumonisin B1 (ceramide synthase inhibitor) and then radiolabeled with [U-¹⁴C]galactose in the continued presence of inhibitors. Gangliosides were extracted, purified and analyzed by HPTLC. In myofibroblast-like cells, simple gangliosides use the de novo pathway while complex gangliosides are mainly synthesized by recycling pathways. In lipocyte-like cells, de novo pathway has a lesser contribution and this is in agreement with the lower activity of the committed enzyme of sphingolipid synthesis (SPT) detected in this phenotype. SPT mRNA has an identical expression in both phenotypes. It was also observed that gangliosides doublets from myofibroblast-like cells have the same distribution between triton soluble and insoluble fractions (upper band > lower band) while the gangliosides doublets from lipocyte-like cells show an inversion in the insoluble fraction (lower band > upper band) in comparison to soluble fraction. These results indicate that myofibroblast- and lipocyte-like cells have important differences between the glycosphingolipid biosynthetic pathways, which could contribute with the respective glycosphingolipid-enriched membrane microdomain's composition. |
doi_str_mv | 10.1007/s11010-007-9464-z |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_954585128</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2153403441</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-6c89e888f125b8417af0a99fe14d4efe572dc58c9352db1a237f0319f1158b213</originalsourceid><addsrcrecordid>eNqFkk2L1TAUhosoznX0B7jRoKCrak6apMlyGPyCARc6bkPaJvdmaJOapErnX_iPTb0XBEFdnUN43ocTeKvqMeBXgHH7OgFgwHVZa0k5rW_vVDtgbVNTCfJutcMNxrWAtj2rHqR0gwuMAe5XZ9BSirkQu-rHFx2dzi74hIJFe-33owvJDQZ1Za4-H0x2PZp1PnzXa0LOo_KE5oPxIa-zQX3w30xMxYBsDBOa1mBdF0M36pQTygGNbg79ms2v8LRE5w06mGIs3pTNOOpcNGUW0puH1T2rx2QeneZ5df32zefL9_XVx3cfLi-u6p5SyDXvhTRCCAuEdYJCqy3WUloDdKDGGtaSoWeilw0jQweaNK3FDUgLwERHoDmvXh69cwxfF5OymlzartDehCUpySgTDIgo5It_klwA5Qz4f0EChFLBZQGf_QHehCX68l3VMk4oB7LZnv8NIpxTzmUxFQqOVB9DStFYNUc36bgqwGpriTq2RG3r1hJ1WzJPTualm8zwO3GqRQGeHgGrg9L76JK6_kQwlD61ktNy3E_4JMMw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2664669693</pqid></control><display><type>article</type><title>Variations of ganglioside biosynthetic pathways in the phenotype conversion from myofibroblasts to lipocytes in murine hepatic stellate cell line</title><source>Springer Link</source><creator>de Aguirres, Aline B ; Mello, Paola A ; Andrade, Claudia M. B ; Breier, Ana Carolina ; Margis, Rogério ; Guaragna, Regina M ; Borojevic, Radovan ; Guma, Fátima C. R ; Trindade, Vera M. T</creator><creatorcontrib>de Aguirres, Aline B ; Mello, Paola A ; Andrade, Claudia M. B ; Breier, Ana Carolina ; Margis, Rogério ; Guaragna, Regina M ; Borojevic, Radovan ; Guma, Fátima C. R ; Trindade, Vera M. T</creatorcontrib><description>GRX cell line represents hepatic stellate cell and can be transformed from an actively proliferation myofibroblast phenotype into a quiescent fat-storing lipocyte phenotype. Both express the same gangliosides (GM3, GM2, GM1 and GD1a), which are resolved as doublets on HPTLC. Upper/lower band ratio is increased in lipocyte-like cells and the upper band is composed by ceramides with long-chain fatty acids. This study evaluated the contribution of de novo synthesis, sphingosine and Golgi recycling pathways on ganglioside biosynthesis, in both phenotypes. Cells were preincubated with 5 mM β-chloroalanine (SPT: serine palmitoyltransferase inhibitor) or with 25 μM fumonisin B1 (ceramide synthase inhibitor) and then radiolabeled with [U-¹⁴C]galactose in the continued presence of inhibitors. Gangliosides were extracted, purified and analyzed by HPTLC. In myofibroblast-like cells, simple gangliosides use the de novo pathway while complex gangliosides are mainly synthesized by recycling pathways. In lipocyte-like cells, de novo pathway has a lesser contribution and this is in agreement with the lower activity of the committed enzyme of sphingolipid synthesis (SPT) detected in this phenotype. SPT mRNA has an identical expression in both phenotypes. It was also observed that gangliosides doublets from myofibroblast-like cells have the same distribution between triton soluble and insoluble fractions (upper band > lower band) while the gangliosides doublets from lipocyte-like cells show an inversion in the insoluble fraction (lower band > upper band) in comparison to soluble fraction. These results indicate that myofibroblast- and lipocyte-like cells have important differences between the glycosphingolipid biosynthetic pathways, which could contribute with the respective glycosphingolipid-enriched membrane microdomain's composition.</description><identifier>ISSN: 0300-8177</identifier><identifier>EISSN: 1573-4919</identifier><identifier>DOI: 10.1007/s11010-007-9464-z</identifier><identifier>PMID: 17440688</identifier><language>eng</language><publisher>Netherlands: Boston : Springer US</publisher><subject>Adipocytes ; Adipocytes - cytology ; Adipocytes - metabolism ; Adipocytes - physiology ; Animals ; Biosynthesis ; Biosynthetic Pathways ; Cell Line ; Ceramide ; Fatty acids ; Fibroblasts - cytology ; Fibroblasts - metabolism ; Fumonisin B1 ; Galactose ; Ganglioside synthesis ; Gangliosides ; Gangliosides - metabolism ; Gene expression ; Genotype & phenotype ; Glycosphingolipid salvage pathways ; Golgi apparatus ; Hepatic stellate cell ; Hepatocytes - cytology ; Hepatocytes - metabolism ; Inhibitors ; Liver ; Mice ; mRNA ; Myoblasts - cytology ; Myoblasts - physiology ; Palmitoyltransferase ; Phenotype ; Phenotypes ; Proteins ; Serine - metabolism ; Serine C-Palmitoyltransferase - metabolism ; Serine palmitoyltransferase ; Sphingolipids - chemistry ; Sphingolipids - metabolism ; Sphingomyelins - chemistry ; Sphingomyelins - metabolism ; β-chloroalanine</subject><ispartof>Molecular and cellular biochemistry, 2007-09, Vol.303 (1-2), p.121-130</ispartof><rights>Springer Science+Business Media, LLC 2007.</rights><rights>Springer Science+Business Media, LLC 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-6c89e888f125b8417af0a99fe14d4efe572dc58c9352db1a237f0319f1158b213</citedby><cites>FETCH-LOGICAL-c441t-6c89e888f125b8417af0a99fe14d4efe572dc58c9352db1a237f0319f1158b213</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17440688$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Aguirres, Aline B</creatorcontrib><creatorcontrib>Mello, Paola A</creatorcontrib><creatorcontrib>Andrade, Claudia M. B</creatorcontrib><creatorcontrib>Breier, Ana Carolina</creatorcontrib><creatorcontrib>Margis, Rogério</creatorcontrib><creatorcontrib>Guaragna, Regina M</creatorcontrib><creatorcontrib>Borojevic, Radovan</creatorcontrib><creatorcontrib>Guma, Fátima C. R</creatorcontrib><creatorcontrib>Trindade, Vera M. T</creatorcontrib><title>Variations of ganglioside biosynthetic pathways in the phenotype conversion from myofibroblasts to lipocytes in murine hepatic stellate cell line</title><title>Molecular and cellular biochemistry</title><addtitle>Mol Cell Biochem</addtitle><description>GRX cell line represents hepatic stellate cell and can be transformed from an actively proliferation myofibroblast phenotype into a quiescent fat-storing lipocyte phenotype. Both express the same gangliosides (GM3, GM2, GM1 and GD1a), which are resolved as doublets on HPTLC. Upper/lower band ratio is increased in lipocyte-like cells and the upper band is composed by ceramides with long-chain fatty acids. This study evaluated the contribution of de novo synthesis, sphingosine and Golgi recycling pathways on ganglioside biosynthesis, in both phenotypes. Cells were preincubated with 5 mM β-chloroalanine (SPT: serine palmitoyltransferase inhibitor) or with 25 μM fumonisin B1 (ceramide synthase inhibitor) and then radiolabeled with [U-¹⁴C]galactose in the continued presence of inhibitors. Gangliosides were extracted, purified and analyzed by HPTLC. In myofibroblast-like cells, simple gangliosides use the de novo pathway while complex gangliosides are mainly synthesized by recycling pathways. In lipocyte-like cells, de novo pathway has a lesser contribution and this is in agreement with the lower activity of the committed enzyme of sphingolipid synthesis (SPT) detected in this phenotype. SPT mRNA has an identical expression in both phenotypes. It was also observed that gangliosides doublets from myofibroblast-like cells have the same distribution between triton soluble and insoluble fractions (upper band > lower band) while the gangliosides doublets from lipocyte-like cells show an inversion in the insoluble fraction (lower band > upper band) in comparison to soluble fraction. These results indicate that myofibroblast- and lipocyte-like cells have important differences between the glycosphingolipid biosynthetic pathways, which could contribute with the respective glycosphingolipid-enriched membrane microdomain's composition.</description><subject>Adipocytes</subject><subject>Adipocytes - cytology</subject><subject>Adipocytes - metabolism</subject><subject>Adipocytes - physiology</subject><subject>Animals</subject><subject>Biosynthesis</subject><subject>Biosynthetic Pathways</subject><subject>Cell Line</subject><subject>Ceramide</subject><subject>Fatty acids</subject><subject>Fibroblasts - cytology</subject><subject>Fibroblasts - metabolism</subject><subject>Fumonisin B1</subject><subject>Galactose</subject><subject>Ganglioside synthesis</subject><subject>Gangliosides</subject><subject>Gangliosides - metabolism</subject><subject>Gene expression</subject><subject>Genotype & phenotype</subject><subject>Glycosphingolipid salvage pathways</subject><subject>Golgi apparatus</subject><subject>Hepatic stellate cell</subject><subject>Hepatocytes - cytology</subject><subject>Hepatocytes - metabolism</subject><subject>Inhibitors</subject><subject>Liver</subject><subject>Mice</subject><subject>mRNA</subject><subject>Myoblasts - cytology</subject><subject>Myoblasts - physiology</subject><subject>Palmitoyltransferase</subject><subject>Phenotype</subject><subject>Phenotypes</subject><subject>Proteins</subject><subject>Serine - metabolism</subject><subject>Serine C-Palmitoyltransferase - metabolism</subject><subject>Serine palmitoyltransferase</subject><subject>Sphingolipids - chemistry</subject><subject>Sphingolipids - metabolism</subject><subject>Sphingomyelins - chemistry</subject><subject>Sphingomyelins - metabolism</subject><subject>β-chloroalanine</subject><issn>0300-8177</issn><issn>1573-4919</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkk2L1TAUhosoznX0B7jRoKCrak6apMlyGPyCARc6bkPaJvdmaJOapErnX_iPTb0XBEFdnUN43ocTeKvqMeBXgHH7OgFgwHVZa0k5rW_vVDtgbVNTCfJutcMNxrWAtj2rHqR0gwuMAe5XZ9BSirkQu-rHFx2dzi74hIJFe-33owvJDQZ1Za4-H0x2PZp1PnzXa0LOo_KE5oPxIa-zQX3w30xMxYBsDBOa1mBdF0M36pQTygGNbg79ms2v8LRE5w06mGIs3pTNOOpcNGUW0puH1T2rx2QeneZ5df32zefL9_XVx3cfLi-u6p5SyDXvhTRCCAuEdYJCqy3WUloDdKDGGtaSoWeilw0jQweaNK3FDUgLwERHoDmvXh69cwxfF5OymlzartDehCUpySgTDIgo5It_klwA5Qz4f0EChFLBZQGf_QHehCX68l3VMk4oB7LZnv8NIpxTzmUxFQqOVB9DStFYNUc36bgqwGpriTq2RG3r1hJ1WzJPTualm8zwO3GqRQGeHgGrg9L76JK6_kQwlD61ktNy3E_4JMMw</recordid><startdate>20070901</startdate><enddate>20070901</enddate><creator>de Aguirres, Aline B</creator><creator>Mello, Paola A</creator><creator>Andrade, Claudia M. B</creator><creator>Breier, Ana Carolina</creator><creator>Margis, Rogério</creator><creator>Guaragna, Regina M</creator><creator>Borojevic, Radovan</creator><creator>Guma, Fátima C. R</creator><creator>Trindade, Vera M. T</creator><general>Boston : Springer US</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>7QO</scope><scope>7X8</scope></search><sort><creationdate>20070901</creationdate><title>Variations of ganglioside biosynthetic pathways in the phenotype conversion from myofibroblasts to lipocytes in murine hepatic stellate cell line</title><author>de Aguirres, Aline B ; Mello, Paola A ; Andrade, Claudia M. B ; Breier, Ana Carolina ; Margis, Rogério ; Guaragna, Regina M ; Borojevic, Radovan ; Guma, Fátima C. R ; Trindade, Vera M. T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-6c89e888f125b8417af0a99fe14d4efe572dc58c9352db1a237f0319f1158b213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adipocytes</topic><topic>Adipocytes - cytology</topic><topic>Adipocytes - metabolism</topic><topic>Adipocytes - physiology</topic><topic>Animals</topic><topic>Biosynthesis</topic><topic>Biosynthetic Pathways</topic><topic>Cell Line</topic><topic>Ceramide</topic><topic>Fatty acids</topic><topic>Fibroblasts - cytology</topic><topic>Fibroblasts - metabolism</topic><topic>Fumonisin B1</topic><topic>Galactose</topic><topic>Ganglioside synthesis</topic><topic>Gangliosides</topic><topic>Gangliosides - metabolism</topic><topic>Gene expression</topic><topic>Genotype & phenotype</topic><topic>Glycosphingolipid salvage pathways</topic><topic>Golgi apparatus</topic><topic>Hepatic stellate cell</topic><topic>Hepatocytes - cytology</topic><topic>Hepatocytes - metabolism</topic><topic>Inhibitors</topic><topic>Liver</topic><topic>Mice</topic><topic>mRNA</topic><topic>Myoblasts - cytology</topic><topic>Myoblasts - physiology</topic><topic>Palmitoyltransferase</topic><topic>Phenotype</topic><topic>Phenotypes</topic><topic>Proteins</topic><topic>Serine - metabolism</topic><topic>Serine C-Palmitoyltransferase - metabolism</topic><topic>Serine palmitoyltransferase</topic><topic>Sphingolipids - chemistry</topic><topic>Sphingolipids - metabolism</topic><topic>Sphingomyelins - chemistry</topic><topic>Sphingomyelins - metabolism</topic><topic>β-chloroalanine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Aguirres, Aline B</creatorcontrib><creatorcontrib>Mello, Paola A</creatorcontrib><creatorcontrib>Andrade, Claudia M. B</creatorcontrib><creatorcontrib>Breier, Ana Carolina</creatorcontrib><creatorcontrib>Margis, Rogério</creatorcontrib><creatorcontrib>Guaragna, Regina M</creatorcontrib><creatorcontrib>Borojevic, Radovan</creatorcontrib><creatorcontrib>Guma, Fátima C. R</creatorcontrib><creatorcontrib>Trindade, Vera M. T</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular and cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Aguirres, Aline B</au><au>Mello, Paola A</au><au>Andrade, Claudia M. B</au><au>Breier, Ana Carolina</au><au>Margis, Rogério</au><au>Guaragna, Regina M</au><au>Borojevic, Radovan</au><au>Guma, Fátima C. R</au><au>Trindade, Vera M. T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Variations of ganglioside biosynthetic pathways in the phenotype conversion from myofibroblasts to lipocytes in murine hepatic stellate cell line</atitle><jtitle>Molecular and cellular biochemistry</jtitle><addtitle>Mol Cell Biochem</addtitle><date>2007-09-01</date><risdate>2007</risdate><volume>303</volume><issue>1-2</issue><spage>121</spage><epage>130</epage><pages>121-130</pages><issn>0300-8177</issn><eissn>1573-4919</eissn><notes>http://dx.doi.org/10.1007/s11010-007-9464-z</notes><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><notes>ObjectType-Article-2</notes><notes>ObjectType-Feature-1</notes><abstract>GRX cell line represents hepatic stellate cell and can be transformed from an actively proliferation myofibroblast phenotype into a quiescent fat-storing lipocyte phenotype. Both express the same gangliosides (GM3, GM2, GM1 and GD1a), which are resolved as doublets on HPTLC. Upper/lower band ratio is increased in lipocyte-like cells and the upper band is composed by ceramides with long-chain fatty acids. This study evaluated the contribution of de novo synthesis, sphingosine and Golgi recycling pathways on ganglioside biosynthesis, in both phenotypes. Cells were preincubated with 5 mM β-chloroalanine (SPT: serine palmitoyltransferase inhibitor) or with 25 μM fumonisin B1 (ceramide synthase inhibitor) and then radiolabeled with [U-¹⁴C]galactose in the continued presence of inhibitors. Gangliosides were extracted, purified and analyzed by HPTLC. In myofibroblast-like cells, simple gangliosides use the de novo pathway while complex gangliosides are mainly synthesized by recycling pathways. In lipocyte-like cells, de novo pathway has a lesser contribution and this is in agreement with the lower activity of the committed enzyme of sphingolipid synthesis (SPT) detected in this phenotype. SPT mRNA has an identical expression in both phenotypes. It was also observed that gangliosides doublets from myofibroblast-like cells have the same distribution between triton soluble and insoluble fractions (upper band > lower band) while the gangliosides doublets from lipocyte-like cells show an inversion in the insoluble fraction (lower band > upper band) in comparison to soluble fraction. These results indicate that myofibroblast- and lipocyte-like cells have important differences between the glycosphingolipid biosynthetic pathways, which could contribute with the respective glycosphingolipid-enriched membrane microdomain's composition.</abstract><cop>Netherlands</cop><pub>Boston : Springer US</pub><pmid>17440688</pmid><doi>10.1007/s11010-007-9464-z</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0300-8177 |
ispartof | Molecular and cellular biochemistry, 2007-09, Vol.303 (1-2), p.121-130 |
issn | 0300-8177 1573-4919 |
language | eng |
recordid | cdi_proquest_miscellaneous_954585128 |
source | Springer Link |
subjects | Adipocytes Adipocytes - cytology Adipocytes - metabolism Adipocytes - physiology Animals Biosynthesis Biosynthetic Pathways Cell Line Ceramide Fatty acids Fibroblasts - cytology Fibroblasts - metabolism Fumonisin B1 Galactose Ganglioside synthesis Gangliosides Gangliosides - metabolism Gene expression Genotype & phenotype Glycosphingolipid salvage pathways Golgi apparatus Hepatic stellate cell Hepatocytes - cytology Hepatocytes - metabolism Inhibitors Liver Mice mRNA Myoblasts - cytology Myoblasts - physiology Palmitoyltransferase Phenotype Phenotypes Proteins Serine - metabolism Serine C-Palmitoyltransferase - metabolism Serine palmitoyltransferase Sphingolipids - chemistry Sphingolipids - metabolism Sphingomyelins - chemistry Sphingomyelins - metabolism β-chloroalanine |
title | Variations of ganglioside biosynthetic pathways in the phenotype conversion from myofibroblasts to lipocytes in murine hepatic stellate cell line |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T14%3A41%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Variations%20of%20ganglioside%20biosynthetic%20pathways%20in%20the%20phenotype%20conversion%20from%20myofibroblasts%20to%20lipocytes%20in%20murine%20hepatic%20stellate%20cell%20line&rft.jtitle=Molecular%20and%20cellular%20biochemistry&rft.au=de%20Aguirres,%20Aline%20B&rft.date=2007-09-01&rft.volume=303&rft.issue=1-2&rft.spage=121&rft.epage=130&rft.pages=121-130&rft.issn=0300-8177&rft.eissn=1573-4919&rft_id=info:doi/10.1007/s11010-007-9464-z&rft_dat=%3Cproquest_cross%3E2153403441%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c441t-6c89e888f125b8417af0a99fe14d4efe572dc58c9352db1a237f0319f1158b213%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2664669693&rft_id=info:pmid/17440688&rfr_iscdi=true |